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The importance of hearing integrity within the first 3 to 4 years after birth for normal acquisition of speech and language has long been appreciated. 4 During this sensitive period, speech and language will almost always develop rapidly, and normally, if the auditory and language regions of the brain are adequately stimulated by sound and, especially, the sounds of communication. Unfortunately, by the time hearing loss in infancy and early childhood is suspected, audiologically evaluated, and appropriately managed, 2 or more of these communicatively important years have elapsed, and the child has lost an enormous developmental advantage. The rationale for early identification of and intervention for hearing impairment in infants, then, is to optimize language and communication development. During the 1960s, there was also interest in hearing screening of children in Europe. 5, 6 In the early 1970s, Dr. Downs was instrumental in organizing the first Joint Committee on Infant Hearing and a risk registry approach to identify those infants most likely to have hearing impairment. Risk factors developed by the Joint Committees on Infant Hearing were widely accepted by audiologists and public health personnel and utilized, to a lesser extent, by pediatricians. Joint Committee on Infant Hearing 7, 8 risk indicators are summarized in Table 1 . The risk register is a form of newborn hearing screening and has played an important role in the identification of many hearing-impaired infants. By the mid-1980s, however, it became clear that approximately one half of children who were eventually diagnosed with communicatively important, permanent, sensorineural hearing impairment was born as healthy infants in well-baby nurseries and had none of these risk indicators. 9 That is, even when applied as intended, the risk registry approach failed to identify about 50% of children with significant hearing loss.
Early identification of infant hearing impairment was altered dramatically by the discovery in 1971 of the auditory brainstem response (ABR) by Jewett and Williston 10 and a subsequent paper by Hecox and Galambos 11 in 1974 describing the clinical application of ABR in auditory assessment of infants and young children. Within the next decade, numerous accounts of newborn hearing screening with ABR of at-risk infants were published by audiologists and others at hospitals and medical centers across the United States (see Hall 12 ). Initially, failure rates were rather high (e.g., over 20%) in some of these early studies. 13 ± 16 As clinical experience accumulated, and screening equipment, techniques, and strategies were modified, the reported failure rates decreased to under 10%. 17, 18 Otoacoustic emissions (OAE) were discovered in 1978 by Kemp 19 and, within several years, were utilized in newborn hearing screening. 20, 21 Experience with OAEs in newborn hearing screening has led to major modifications in equipment design and, more recently, lower failure rates. Four lessons learned from experience in newborn hearing screening with OAEs are noteworthy. First, within the first week after birth, failure rate, on the average, decreases as a function of the time (number of days) at which the screening is performed. Infant age after birth is a major factor in OAE screening outcome. OAE failure rate is highest within the initial 24 hours after birth, and then decreases markedly over the next 3 to 4 days. 22 Second, noise in the nursery plays an important role in the success and outcome of newborn hearing screening with OAEs. 23 Since environmental and physiologic (baby-generated) noise is greater within a lower-frequency region (below about 1500 Hz), hearing screening with OAEs can be remarkably enhanced by limiting the recording to the higher frequencies, which are important for speech understanding. Third, tester experience in recording OAEs from infants in the nursery setting profoundly influences newborn hearing With the identification of hearing loss at birth and appropriate intervention within 6 months after birth, language can develop normally, even in children with severe hearing impairment. Universal newborn hearing screening ( UNHS ) is now endorsed by numerous national groups, including the American Academy of Pediatrics. Two electrophysiologic techniques Ð automated auditory brainstem response ( ABR ) and otoacoustic emissions ( OAEs ) Ð are used for the identification of communicatively significant hearing loss in newborn infants. UNHS is legislatively supported by more than one half of the United States, including the most populous. Successful hearing screening and intervention programs require the support and expertise of pediatricians, including perinatologists. Journal of Perinatology 2000; 20:S112 ± S120.
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screening failure rates. 24 An excellent example of the importance of tester experience is provided by the Rhode Island Hearing Assessment Program Ð without doubt the single most ambitious and longstanding universal hearing screening effort in the United States. This study is described below. Fourth, OAE test protocols that are appropriate for successful diagnostic measurements in adults must be modified to be effective in newborn hearing screening. When these factors are taken into account, newborn hearing screening test performance with OAEs can meet criteria set by the American Academy of Pediatrics.
Benefits of Early Intervention for Hearing Impairment in Children
Is the outcome of children with congenital hearing loss improved if intervention is initiated in infancy versus later in their children?
This question, raised in an essay by Bess and Paradise, 25 is fundamental to the rationale for universal newborn hearing screening (UNHS). Although untold numbers of clinical audiologists, young and old, would readily reply``yes'' based on their experiences with individual patients, the published evidence in support of intervention within 6 months after birth was, until recently, anecdotal or limited to a modest number of case studies. 26 Formal studies of the benefits of intervention on communication abilities, often not published in peer-reviewed journals, tended to focus on hearing-impaired children aged 1 year and older. Yoshinaga-Itano et al. 27 at the University of Colorado are conducting the definitive investigation of the benefits of early intervention on language abilities of children with hearing impairment. The findings of this very thorough and detailed study (at least through 1998) are summarized in Table  2 . Secondary to the marked positive influence of early intervention on language acquisition are clear academic, cognitive, social, and economic benefits. 28 Current Status of Newborn Hearing Screening UNHS is now a powerful and widespread professional and technological movement within the United States. Legislation in support of UNHS has been enacted in almost half of the states, including the four most populous (New York, Texas, California, and Florida). Federal legislation to provide financial support to statewide efforts to develop UNHS programs is now forthcoming. Moreover, UNHS is endorsed by three well-respected, multidisciplinary bodies with an interest in the early detection of hearing loss in children, including an NIH panel of experts 29 (1993), the Joint Committee on Infant Hearing 7, 8, 29 in 1994, and again in 2000, and by the American Academy of Pediatrics 30 in 1999. The position statement of this latter group, summarized in Table 3 , provides practical guidelines and objectives for each stage of the process of early identification of and intervention for hearing impairment in infants and young children. UNHS is also a health priority in Europe, where the progressive recommendations of a Consensus Conference held in 1998 are being implemented.
Newborn Hearing Screening Techniques
Introduction. Criteria for an acceptable newborn hearing screening technique, and feasible techniques at this time, are clearly defined by the Joint Committee on Infant Hearing. The technique must be capable of detecting hearing loss of 30 dB HL and greater in the frequency region important for speech recognition that will interfere with the normal development of speech and language. Techniques used to assess hearing of infants must be capable of detecting hearing loss of this degree in infants aged 3 months and younger. Of the various approaches to newborn hearing assessment currently available, two physiologic measures Ð ABR and OAE Ð show good promise for achieving this goal (Joint Committee on Infant Hearing 7, 8, 29 ). Craniofacial anomalies including abnormalities of the pinna and ear canal, absent philtrum, and low hairline Birth weight less than 1500 g (3.3 lb); hyperbilirubinemia at level requiring exchange transfusion Ototoxic medications including, but not limited to, the aminoglycosides (e.g., gentamicin, tobramycin, kanamycin, streptomycin) used in multiple courses or in combination with loop diuretics Bacterial meningitis Apgar scores of 0 to 4 at 1 minute or 0 to 6 at 5 minutes Mechanical ventilation lasting 5 days or longer Stigmata or other findings associated with a syndrome known to include sensorineural and/or conductive hearing loss (e.g., Waardenburg or Usher's syndrome) Age 29 days through 2 years (infant) Parent caregiver concern regarding hearing, speech, language, and/or developmental delay Bacterial meningitis and other infections associated with sensorineural hearing loss Ototoxic medications including, but not limited to, chemotherapeutic agents or aminoglycosides used in multiple courses or in combination with loop diuretics Recurrent or persistent otitis media with effusion for at least 3 months ABR. Auditory-evoked responses are electrophysiologic recordings of responses to sounds. With proper test protocols, the responses can be recorded clinically from activation of all levels of the auditory system, from the cochlea to the cortex. 12 Among these responses, the ABR (often referred by neurologists as the brainstem auditory-evoked response or BAER) is applied most often clinically. An ABR recording is shown schematically in Figure 1 . The ABR is generated with transient acoustic stimuli (clicks or tonebursts) and detected with surface electrodes (disks) placed on the forehead and near the ears (earlobe or within external ear canal). Using a commercially available computer-based device, it is possible to present rapidly (e.g., at rates of 20 to 30 per second) thousands of sound stimuli and to average reliable ABR waveforms in a matter of minutes. Extensive research has shown that the ABR wave components arise from the eighth cranial nerve and auditory regions in the caudal and rostral brainstem. Wave I unquestionably represents the synchronously stimulated compound action potentials from the distal (cochlear) end of the eighth cranial nerve. Wave II may also arise from the eighth nerve, but near the brainstem (the proximal end). Waves I and II are generated by structures ipsilateral to the ear stimulated. All later ABR waves have multiple generators within the auditory brainstem. Wave III, which is usually prominent, is generated within the caudal pons, with likely contributions from the cochlear nuclei, the trapezoid body, and the superior olivary complex. 12 The most prominent and rostral component of the ABR Ð wave V Ð is thought to arise in the region of the lateral lemniscus as it approaches the inferior colliculus, probably on the side contralateral to the ear stimulated.
In ABR waveform analysis, the first objective is to assure that the response is reliably recorded. Minimally, two replicated waveforms should be averaged. If the response is not highly replicable, modifications in the test protocol should be made, and then potential technical problems must be considered and systematically ruled out. When a replicable response is confirmed, absolute latencies for each replicable wave component and relative (interwave) latencies between components are calculated in milliseconds, and usually compared to appropriate normative data. When applying the ABR in newborn hearing screening, waveform analysis is typically limited to the identification of a reliable wave V component within the expected latency region for a newborn infant. There are now automated ABR devices on the market designed specifically for newborn hearing screening by nonprofessional testers. 12 With devices, stimulus presentation and response analysis are under the control of computer-based algorithms and statistical criteria.
During the past decade, millions of babies have been successfully screened with the automated ABR technique. As described in another paper in this issue of the Journal of Perinatology, the results of a recent multisite investigation (see Stewart et al., J Perinatol 2000; 20: S124±S127) confirm that automated ABR test performance is well within guidelines established by the American Academy of Pediatrics. Methodology Subjects were 150 hearing-impaired children (72 whose hearing losses were identified between birth and 6 months and 78 identified later). Intervention included amplification and ongoing individualized family-oriented communication/language intervention strategies implemented within 2 months after identification. Demographic characteristics for subjects in the early and later identified groups were carefully documented, including: o gender o ethnicity o mother's education o medicaid status o degree of hearing loss (all subjects had congenital, bilateral, sensorineural hearing loss) o mode of communication (oral only, or oral and sign language) o multiple handicaps o cognitive ability (quantified with a cognitive quotient) o age at data collection (between 13 and 36 months) Children underwent a comprehensive developmental evaluation (Minnesota Child Development Inventory or MCDI) which included standardized scales for expressive (54 items) and comprehension ± conceptual (67 items) language function. Language status was summarized by a composite language quotient.
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Findings and conclusions
Children with hearing loss who were identified by 6 months after birth showed significantly better expressive and receptive language skills (higher language quotients) than later-identified children. The effect of age of identification was found across all of the demographic variables (noted above). The benefits of early identification were found for all degrees of hearing impairment, from mild to profound. There was no significant difference in language performance among four groups of later-identified subjects (from 7 to 25 months of age). That is, the benefits of early identification occur only before 6 months (early intervention 6 months). For children with hearing impairment, the first 6 months after birth are very important, even critical. For children with congenital hearing impairment of any degree, language can develop on a normal schedule if intervention is begun by 6 months.
Source: Ref. 27 as adapted by Hall. 31 
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OAEs. OAEs are low-intensity sounds produced by the cochlea in response to an acoustic stimulus. A moderate intensity click or an appropriate combination of two tones can evoke outer hair cell movement or motility. 31 Outer hair cell motility affects basilar membrane biomechanics, resulting in a form of intracochlear energy amplification, as well as cochlear tuning for more precise frequency resolution. The outer hair cell motility generates mechanical energy within the cochlea which is propagated outward, via the middle ear system and the tympanic membrane, to the ear canal. Vibration of the tympanic membrane then produces an acoustic signal (the OAE), which can be measured by a sensitive microphone. There are two broad classes of OAEs: spontaneous and evoked. Spontaneous OAEs, present in only about 70% of persons with normal hearing, are measured in the external ear canal where there is no external sound stimulation. A significant gender effect for spontaneous OAEs has been confirmed, with females demonstrating spontaneous OAEs at twice the rate of males.
Evoked OAEs, elicited by moderate levels (50 to 80 dB SPL) of acoustic stimulation in the external ear canal, are generally classified according to characteristics of the stimuli used to elicit them or characteristics of the cochlear events that generate them.
Distortion product OAEs are produced when two pure tone stimuli at frequencies f H 1 and f 2 are presented to the ear simultaneously (Figure 2) . The most robust distortion product OAEs occur at the Guidelines for the screening portion of a UNHS program o At least 95% of newborns must be screened using a physiologic measure in both ears (the goal is 100% of the target population). o Screening must detect bilateral hearing loss > 35 dB HL. o The false-positive rate for the screening technique (the percent of infants without hearing loss who fail the screening) should be < 3%, and the referral rate for ubsequent formal audiologic assessment should be 4% or less. o The screening technique should not miss any baby with hearing loss (a false-negative rate of 0%). o``OAE and ABR, either alone or together, are acceptable screening methods, as both techniques are non-invasive, quick ( < 5 minutes), and easy to perform.'' (p. 527) o Hospitals where babies are born should set up a UNHS program, designate a medical (physician) director, and assemble an adequate staff (the statement includes a listing of 10 detailed guidelines on the objectives and activities included in the screening program).
Guidelines for the tracking and follow-up portion of UNSH program
For a program to be considered effective, at least 95% of all babies with a refer screening outcome initially should undergo follow-up diagnostic assessment (the goal is 100%). The same guideline applies for those infants who are not screened in the hospital and whose parents agreed to the screening. Guidelines for the identification and intervention portion of a UNHS program o The goal of universal screening is to identify all (100%) infants who are born with hearing loss (see above criteria) by 3 months after birth, and to intervene appropriately by 6 months. o The child's physician should direct and coordinate care for the child with hearing impairment, with appropriate support from others. o To provide expert services to infants with hearing loss, a regionalized approach to identification and intervention is necessary. o Training and education of additional expert care providers will be needed due to the increased demand associated with the implementation of UNHS programs.
Guidelines for the evaluation portion of a UNHS program o Quality control should be maintained for each UNHS program by the state monitoring system. o This system should also evaluate regularly the tracking and follow-up components of UNHS programs. o In addition, state departments of health system should evaluate regularly the intervention services within UNHS programs. Journal of Perinatology 2000; 20:S112 ± S120
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Hall frequency determined by the equation, 2fÀf 2 , whereas the actual cochlear frequency region that is assessed with distortion product OAE is between these two frequencies, and probably close to the f 2 stimulus for recommended test protocols. 31 Transiently evoked OAEs are elicited by brief acoustic stimuli such as clicks or tonebursts. Although there are distinct differences in the methodology for recording distortion product OAEs versus transiently evoked OAEs, and the exact cochlear mechanisms responsible for their generation are also different, each type of evoked OAE is now being incorporated into routine auditory assessment of children and adults, including newborn hearing screening. 31 And, as with ABR, devices permitting automated OAE measurement and analysis and designed primarily for newborn hearing screening are now available from a variety of manufacturers. Most of these devices are handheld and very simple to operate.
The use of OAEs in newborn hearing screening is exemplified by the 1998 paper by Vohr et al. 32 describing the Rhode Island Hearing Assessment Project experience over a 5-year period. The initial refer rate for the Rhode Island Hearing Assessment Project decreased from 27% in the early years to 8% in 1996. The overall``first'' refer rate for a total of 53,121 babies (47,991 normal nursery and 5130 NICU) was 10%. Importantly,``only 14.7% of the rescreens failed the transiently evoked TEOAE when performed at 2 to 6 weeks of age, supporting the efficiency of a 2-stage process for hearing screening. This process resulted in an overall 1.2% refer rate, indicating a more than acceptable audiology diagnostic refer rate for a hearing screening program'' (Ref., 32 p. 356). Both OAE and ABR technologies are widely used for newborn hearing screening, and both are endorsed by major professional organizations and committees with an interest in early identification of hearing impairment in children. In addition, the technologies share features, including automation and diminutive size, which are essential for their application in UNHS. There are, however, differences between the two techniques in test performance and other practical clinical factors (e.g., speed of screening, effect of vernix, and screening cost) which in turn depend on a variety of parameters, such as the population screened, the test setting, and the timing of the screening after birth. All of these factors should be taken into account in determining which technique, and even which specific screening device, is optimal for a given UNHS program. At this time, unfortunately, no more than 25% of the 3,900,000 babies born annually in the United States undergo hearing screening as neonates. Each year, an estimated 8780 babies with serious hearing impairment are not screened. It is likely that these statistics will change substantially within the next few years with the expansion of UNHS among the United States and throughout the world.
After the screening: database management, tracking, and follow-up. Newborn hearing screening is of no value if the final outcome is not early identification and intervention of permanent hearing loss in infants and young children. Hearing screening is the first step in a challenging clinical process that, for infants with hearing impairment, often continues throughout childhood. Important components of a comprehensive newborn hearing screening program are illustrated in Figure 3 . Most of these components were summarized in the 1999 American Academy of Pediatrics statement (see Table 3 ). With a screening failure in the nursery, the initial follow-up visit is often a secondary Figure 3 . Schematic illustration of the generation of distortion product OAEs. OAEs are a reflection of cochlear outer hair cell movements (and outer hair cell integrity) that occur in response to an acoustic stimulus. Solid arrows represent stimulation with tones or clicks used to evoke OAEs, whereas the dashed arrows represent the OAE energy being produced and emitted by the cochlea.
screening, either in the hospital or within weeks after discharge. A diagnostic pediatric audiology assessment to confirm and define hearing loss is scheduled after the refer outcome for the final screening. Although this assessment will be performed by audiologists, it is scheduled by or following consultation with the child's primary care physician. By definition, early intervention is initiated within 4 to 6 months after birth (see Table 2 ). Therefore, the diagnostic pediatric assessment should be conducted within 2 to 3 months after the final screening failure (or by 2 to 3 months of chronologic age relative to term birth) so that intervention (including amplification) can occur within the first 6 months after birth. Another practical reason for scheduling the diagnostic assessment early is to avoid the need for sedation, at least for this first session.
ASSESSMENT OF HEARING IN CHILDREN
There is a substantial literature on the strategies and protocols for diagnostic pediatric assessment. 33, 34 Age-appropriate pediatric hearing assessment techniques are summarized in Table 4 . For some infants failing the hearing screening, diagnostic assessment will rule out hearing loss and the child will require no further audiologic management, unless there is a risk factor for progressive or delayed-onset hearing impairment (Figure 3) . Hearing loss will be confirmed, however, for a proportion of infants. It is this small, but significant, group that requires the prompt and diligent efforts of the child's family and a team of professionals, including the audiologist, primary care physician, speech±language pathologist, and, often, medical specialists (otolaryngologists, geneticists, pediatric neurologist). The many critical details involved in the management of infant hearing impairment are far beyond the scope of this paper.
There are at least three principles of pediatric hearing assessment today that contribute to accurate description of auditory status and, therefore, lead to a rationale and evidencebased strategy for effective management. First, a test battery approach is essential in the evaluation of hearing in children of any age. With the advent of newborn hearing screening, there is increased demand for diagnostic audiologic assessment of infants under the age of 4 months. That is, infants who do not pass a hearing screening at birth require follow-up evaluation within months to confirm and define the hearing impairment so that intervention can begin before 6 months after birth. The initial description of the type and degree of hearing loss for each ear is based typically on electrophysiologic procedures (see Table 4 ). The information is essential for determining whether hearing aids are indicated and, if so, the specifications of the hearing aid selection and fitting. Reasonable accurate electrophysiologic estimations of auditory thresholds for three or four data points within the speech frequency region permit precise``prescriptive'' hearing aid selection and fitting, 35 even in infants as young as 2 to 3 months. The hearing aid fitting will later be adjusted and refined as the hearing impairment is better defined with behavioral audiometry (Table 4) . Although electrophysiologic measures of auditory function are invaluable during infancy, only behavioral measures truly reflect a child's hearing status. Second, the audiologic evaluation should lead to a differentiation of the type of hearing loss, the general site of lesion, and, along with other medical studies, a diagnosis. Examples of types of hearing loss include conductive (middle ear dysfunction), sensory (cochlear dysfunction), neural (eighth cranial nerve and/or central auditory nervous system), or combinations of these types. Thus, in addition to estimation of hearing thresholds, the objective of audiometry in infants must provide accurate information on the site of dysfunction within the auditory system. The importance of diagnostic pediatric assessment is easily appreciated by considering the distinctly divergent management approaches taken with three clinical entities all presenting with elevated (abnormal) auditory thresholds for air-conducted signals, but otherwise very different patterns of auditory findings. Middle ear disease or malformation can be identified by abnormal immittance findings, and better auditory thresholds for bone versus air conduction stimulation with either ABR or pure tone audiometry. Prompt identification of middle ear disease with proper referral can lead to successful medical management and eliminate the need for amplification. A variety of pediatric diseases are associated with cochlear dysfunction. Some were among the Joint Committee on Infant Hearing risk indicators (Table 1) . Diagnosis of the cause for sensory hearing loss may require radiologic studies and laboratory tests. Audiologic findings for OAEs and ABR, and pure tone audiometry for older children, can almost always confirm a sensory hearing loss and even differentiate between outer and inner hair cell dysfunction. Amplification, rather than medical therapy, is the most common management strategy for a pure sensory deficit. Management is radically different for a third and recently described clinical entity Ð auditory neuropathy. Comprehensive diagnostic audiometry for a small proportion of infants with hearing impairment shows normal cochlear function. Based on ABR or behavioral measures, the loss may initially appear to be sensory in nature. Yet, OAE recordings are normal, confirming cochlear outer hair cell integrity. Complete medical diagnostic work up typically yields the diagnosis of a disorder secondary to neurologic dysfunction, e.g., cerebral palsy or developmental delay. Although children with auditory neuropathy are most often graduates of the intensive care nursery, there are reports of auditory neuropathy also in the well-baby population. One of the most common risk factors for auditory neuropathy is hyperbilirubinemia. Audiologic management is markedly different for auditory neuropathy versus more common sensory hearing impairment. Since cochlear function is intact with auditory neuropathy, a hearing aid or cochlear implant is not immediately indicated and, in fact, is clearly contraindicated. Most children with this pattern of audiologic findings are candidates for multidisciplinary diagnostic evaluations in a child development center setting. Management strategies are highly variable depending on the exact auditory and neurologic findings. 31 Third, auditory measures used for diagnostic assessment must be age-appropriate. All auditory responses in early childhood are affected to some degree by either peripheral and/or central auditory system maturation, and vary as a function of age. Even electrophysiologic findings must be interpreted with reference to age-appropriate normative data. For behavioral audiometry, however, the actual procedures used and the entire test strategy are highly dependent on a child's developmental age (see Table 4 ). In the hands of an inexperienced audiologist, or without full appreciation of the most age-appropriate test approach, sophisticated behavioral audiometry test procedures may yield an unreliable and invalid reflection of hearing status. Serious mismanagement of pediatric hearing impairment can result.
CONCLUDING COMMENT
UNHS in the United States is rapidly becoming a reality. The resulting early identification of and intervention for infant hearing impairment will yield unprecedented communicative, academic, cognitive, and economic dividends. Effective programs for early identification of and intervention for hearing impairment are highly dependent, however, on a well-coordinated multidisciplinary strategy involving pediatricians, other medical specialists, audiologists, nurses, parents, parent± infant specialists, hospital administrators, and personnel in state departments of health and education. Professionals in all of these disciplines will be required to update their knowledge and clinical skills to meet the challenges of UNHS. Perinatologists will play a critical role in the successful implementation of UNHS and the enhanced outcome of the many thousands of hearing-impaired babies born each year in the United States.
